Trends in the surgical treatment of ulcerative colitis over time: Increased mortality and centralization of care

World Journal of Surgery

Volumn 35, Issue 3, 2011, Pages 671-676

  Ellis, Michelle C ^a   Diggs, Brian S ^a   Vetto, John T ^a   Herzig, Daniel O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGE; ARTICLE; COLON RESECTION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; FORECASTING; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; REGISTER; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNITED STATES;

AGE FACTORS; ANTIBODIES, MONOCLONAL; COLECTOMY; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROCTOCOLECTOMY, RESTORATIVE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 79952192126     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0910-9     Document Type: Article

References (17)

1. E Langholz P Munkholm M Davidsen, et al. 1994 Course of ulcerative colitis: analysis of changes in disease activity over years Gastroenterology 107 3 11 1:STN:280:DyaK2c3ptFyltw%3D%3D 8020674 (Pubitemid 24195339)
2. H Kunitake R Hodin PC Shellito, et al. 2008 Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications J Gastrointest Surg 12 1730 1736 10.1007/s11605-008-0630-8 18709514 (discussion 1736-1737)
3. Lawson MM, Thomas AG, Akobeng AK (2006) Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2006 Jul 19(3):CD005112
4. EA Russo AW Harris S Campbell, et al. 2009 Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England Aliment Pharmacol Ther 29 308 314 1:CAS:528:DC%2BD1MXitF2js7s%3D 10.1111/j.1365-2036.2008.03890.x 19035973
5. SJ Schluender A Ippoliti M Dubinsky, et al. 2007 Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 50 1747 1753 10.1007/s10350-007-9008-3 17704969 (Pubitemid 350077092)
6. CR Selvasekar RR Cima DW Larson, et al. 2007 Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis J Am Coll Surg 204 956 962 10.1016/j.jamcollsurg.2006.12.044 17481518 (discussion 962-963) (Pubitemid 46661200)
7. G Jarnerot E Hertervig I Friis-Liby, et al. 2005 Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study Gastroenterology 128 1805 1811 10.1053/j.gastro.2005. 03.003 15940615 (Pubitemid 40824691)
8. WJ Sandborn P Rutgeerts BG Feagan, et al. 2009 Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab Gastroenterology 137 1250 1260 1:CAS:528:DC%2BD1MXht12gtr%2FN 10.1053/j.gastro.2009.06.061 19596014 quiz 1520
9. A Aratari C Papi V Clemente, et al. 2008 Colectomy rate in acute severe ulcerative colitis in the infliximab era Dig Liver Dis 40 821 826 1:CAS:528:DC%2BD1cXhsVWis7rE 10.1016/j.dld.2008.03.014 18472316
10. B Bressler JK Law N Al Nahdi Sheraisher, et al. 2008 The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis Can J Gastroenterol 22 937 940 1:STN:280:DC%2BD1cjlt1GhsA%3D%3D 19018340
11. IJ Mor JD Vogel A da Luz Moreira, et al. 2008 Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy Dis Colon Rectum 51 1202 1207 1:STN:280:DC%2BD1cvnslCitA%3D%3D 10.1007/s10350-008-9364-7 18536964 discussion 1207-1210
12. L Bordeianou H Kunitake P Shellito, et al. 2009 Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery Int J Colorectal Dis 25 401 404 10.1007/s00384-009-0800-5 19798508
13. T Longobardi CN Bernstein 2007 Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis Am J Gastroenterol 102 1683 1691 10.1111/j.1572-0241.2007.01232.x 17459026 (Pubitemid 47206679)
14. M Bewtra C Su JD Lewis 2007 Trends in hospitalization rates for inflammatory bowel disease in the united states Clin Gastroenterol Hepatol 5 597 601 10.1016/j.cgh.2007.01.015 17382602 (Pubitemid 46660771)
15. GC Nguyen A Tuskey T Dassopoulos, et al. 2007 Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004 Inflamm Bowel Dis 13 1529 1535 10.1002/ibd.20250 17828784
16. CN Bernstein A Nabalamba 2006 Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study Am J Gastroenterol 101 110 118 10.1111/j.1572-0241.2006.00330.x 16405542 (Pubitemid 43381717)
17. RR Cannom AM Kaiser GT Ault, et al. 2009 Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates? Am Surg 75 976 980 19886148